+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Nanoemulsions: Global Strategic Business Report

  • PDF Icon

    Report

  • 193 Pages
  • March 2024
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5140632

Global Nanoemulsions Market to Reach $18.4 Billion by 2030

The global market for Nanoemulsions estimated at US$10.1 Billion in the year 2022, is projected to reach a revised size of US$18.4 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2022-2030. Topical, one of the segments analyzed in the report, is projected to record 7.5% CAGR and reach US$3.9 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Oral segment is readjusted to a revised 8% CAGR for the next 8-year period.

The U.S. Market is Estimated at $3 Billion, While China is Forecast to Grow at 7.4% CAGR

The Nanoemulsions market in the U.S. is estimated at US$3 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$3.2 Billion by the year 2030 trailing a CAGR of 7.4% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 7.2% and 6.4% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 6.4% CAGR.

Select Competitors (Total 43 Featured) -

  • AbbVie, Inc.
  • Allergan PLC
  • AstraZeneca PLC
  • Covaris, Inc.
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Kaken Pharmaceutical Co., Ltd.
  • NanoBio Corporation
  • Novartis International AG
  • Sanofi SA

What's New?

  • Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
  • Global competitiveness and key competitor percentage market shares
  • Market presence across multiple geographies - Strong/Active/Niche/Trivial
  • Online interactive peer-to-peer collaborative bespoke updates
  • Access to digital archives and the publisher's Research Platform
  • Complimentary updates for one year

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Nanoemulsions - Global Key Competitors Percentage Market Share in 2022 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
  • Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 2: World 8-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2023 & 2030
  • Table 3: World Recent Past, Current & Future Analysis for Topical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 4: World 8-Year Perspective for Topical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Oral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 6: World 8-Year Perspective for Oral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 7: World Recent Past, Current & Future Analysis for Parenteral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 8: World 8-Year Perspective for Parenteral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 9: World Recent Past, Current & Future Analysis for Nasal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 10: World 8-Year Perspective for Nasal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Steroids by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 12: World 8-Year Perspective for Steroids by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 13: World Recent Past, Current & Future Analysis for Anesthetics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 14: World 8-Year Perspective for Anesthetics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 15: World Recent Past, Current & Future Analysis for NSAIDs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 16: World 8-Year Perspective for NSAIDs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Immunosuppressant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 18: World 8-Year Perspective for Immunosuppressant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 19: World Recent Past, Current & Future Analysis for Antiretroviral by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 20: World 8-Year Perspective for Antiretroviral by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 21: World Recent Past, Current & Future Analysis for Antimicrobials by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 22: World 8-Year Perspective for Antimicrobials by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Vasodilators by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 24: World 8-Year Perspective for Vasodilators by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2023 & 2030
  • Table 25: World Nanoemulsions Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
  • UNITED STATES
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
  • Table 26: USA Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 27: USA 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 28: USA Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 29: USA 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • CANADA
  • Table 30: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 31: Canada 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 32: Canada Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 33: Canada 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • JAPAN
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
  • Table 34: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 35: Japan 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 36: Japan Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 37: Japan 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • CHINA
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
  • Table 38: China Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 39: China 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 40: China Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 41: China 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • EUROPE
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
  • Table 42: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
  • Table 43: Europe 8-Year Perspective for Nanoemulsions by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2023 & 2030
  • Table 44: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 45: Europe 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 46: Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 47: Europe 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • FRANCE
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
  • Table 48: France Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 49: France 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 50: France Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 51: France 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • GERMANY
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
  • Table 52: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 53: Germany 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 54: Germany Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 55: Germany 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • ITALY
  • Table 56: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 57: Italy 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 58: Italy Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 59: Italy 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • UNITED KINGDOM
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
  • Table 60: UK Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 61: UK 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 62: UK Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 63: UK 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • REST OF EUROPE
  • Table 64: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 65: Rest of Europe 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 66: Rest of Europe Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 67: Rest of Europe 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • ASIA-PACIFIC
  • Nanoemulsions Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
  • Table 68: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 69: Asia-Pacific 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 70: Asia-Pacific Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 71: Asia-Pacific 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
  • REST OF WORLD
  • Table 72: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Route Of Administration - Topical, Oral, Parenteral and Nasal - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 73: Rest of World 8-Year Perspective for Nanoemulsions by Route Of Administration - Percentage Breakdown of Value Sales for Topical, Oral, Parenteral and Nasal for the Years 2023 & 2030
  • Table 74: Rest of World Recent Past, Current & Future Analysis for Nanoemulsions by Application - Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
  • Table 75: Rest of World 8-Year Perspective for Nanoemulsions by Application - Percentage Breakdown of Value Sales for Steroids, Anesthetics, NSAIDs, Immunosuppressant, Antiretroviral, Antimicrobials and Vasodilators for the Years 2023 & 2030
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AbbVie, Inc.
  • Allergan PLC
  • AstraZeneca PLC
  • Covaris, Inc.
  • Fresenius Kabi AG
  • GlaxoSmithKline PLC
  • Kaken Pharmaceutical Co., Ltd.
  • NanoBio Corporation
  • Novartis International AG
  • Sanofi SA

Table Information